NASDAQ · ZCMD
Zhongchao Inc.
Healthcare · Medical - Healthcare Information Services
$0.99▼ 4.13% ($0.04)at close
Pre-market$0.97▼ 1.38%7:23 AM ET
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
Reported operating earnings and the comparable cash-flow estimate differ substantially; the model retains the reported-margin anchor.
Data notes
Reported operating earnings and the comparable cash-flow estimate differ substantially; the model retains the reported-margin anchor.
- 10-yr revenue CAGR
- 0.8%
- Ending operating margin
- 0.0%
- Discount rate
- 7.9%
USD · TTM ending Dec 31, 2025 · Price used $0.99 · Price Sep 23, 8:00 PM UTC
Your case starts from the selected scenario.
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 99.88% over the last year. Revenue declined 28.3% over the trailing twelve months. Operating margin moved from -2.15% to -54.43%. Free cash flow grew 115.33% over the trailing twelve months.
What the market seems to be pricing
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
What would invalidate this read
Operating margin stands at -54.43%. Revenue declined 28.3% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Return analysis
Company profile
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China.
Market multiples
Stock splits
Every 3 shares became 1
Every 31 shares became 1
Every 8 shares became 1
Every 10 shares became 1
Profitability & growth
Analyst consensus
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 3, 2026
Q3 FY26 · EPS est — · Revenue est —
View
Institutional Sentiment
Zhongchao Inc. · ZCMD
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.